These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1646927)

  • 1. Chronic active hepatitis B. Interferon-activated natural killer-like cells against a hepatoma cell line transfected with the hepatitis B virus nucleic acid.
    Actis GC; Ponzetto A; D'Urso N; Saracco G; Crepaldi T; Bellone G; Catucci LM; Zarcone D; Verme G
    Liver; 1991 Apr; 11(2):106-13. PubMed ID: 1646927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic T lymphocyte activity to hepatitis B virus DNA-transfected HepG2 cells in patients with chronic hepatitis B.
    Ito Y; Kakumu S; Yoshioka K; Wakita T; Ishikawa T; Koike K
    Gastroenterol Jpn; 1993 Oct; 28(5):657-65. PubMed ID: 7693538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro effects of lymphoblastoid interferon on lymphocyte activation and cell-mediated cytolysis in patients with chronic hepatitis B virus infection.
    Alexander GJ; Nouri-Aria KT; Neuberger J; Bakhtiar M; Vogel W; Anderson MG; Magrin S; Eddleston AL; Williams R
    J Hepatol; 1986; 3 Suppl 2():S269-77. PubMed ID: 3110263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating CD56dim natural killer cells and CD56+ T cells that produce interferon-γ or interleukin-10 are expanded in asymptomatic, E antigen-negative patients with persistent hepatitis B virus infection.
    Conroy MJ; Mac Nicholas R; Grealy R; Taylor M; Otegbayo JA; O'Dea S; Mulcahy F; Ryan T; Norris S; Doherty DG
    J Viral Hepat; 2015 Mar; 22(3):335-45. PubMed ID: 25186004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role in nude mice of interferon and natural killer cells in inhibiting the tumorigenicity of human hepatocellular carcinoma cells infected with hepatitis B virus.
    Shouval D; Rager-Zisman B; Quan P; Shafritz DA; Bloom BR; Reid LM
    J Clin Invest; 1983 Aug; 72(2):707-17. PubMed ID: 6192149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
    J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection.
    Rehermann B; Lau D; Hoofnagle JH; Chisari FV
    J Clin Invest; 1996 Apr; 97(7):1655-65. PubMed ID: 8601631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro effect of lymphoblastoid alpha-interferon on subpopulations of effector cells mediating cytotoxicity for autologous hepatocytes in hepatitis B and non-A, non-B.
    Mondelli MU; Alberti A; Realdi G; Rondanelli EG
    Int J Immunopharmacol; 1986; 8(8):887-91. PubMed ID: 3100465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low frequency of cytotoxic liver-infiltrating T lymphocytes specific for endogenous processed surface and core proteins in chronic hepatitis B.
    Löhr HF; Gerken G; Schlicht HJ; Meryer zum Büschenfelde KH; Fleischer B
    J Infect Dis; 1993 Nov; 168(5):1133-9. PubMed ID: 8228346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T lymphocyte subsets implicated in cytotoxicity in autologous hepatocytes in chronic active hepatitis patients with active viral replication.
    Stefanini GF; Mazzetti M; Zunarelli P; Baraldini M; Pignatelli M; Canonica GW; Miglio F; Gasbarrini G
    Clin Immunol Immunopathol; 1986 Aug; 40(2):214-23. PubMed ID: 3487403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural Killer p46 Controls Hepatitis B Virus Replication and Modulates Liver Inflammation.
    Li W; Jiang Y; Wang X; Jin J; Qi Y; Chi X; Zhang H; Feng X; Niu J
    PLoS One; 2015; 10(8):e0135874. PubMed ID: 26291078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer activity in patients with chronic hepatitis treated with OK432, interferon, adenine arabinoside and glycyrrhizin.
    Wada T; Arima T; Nagashima H
    Gastroenterol Jpn; 1987 Jun; 22(3):312-21. PubMed ID: 3040509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective expansion of cytotoxic T lymphocytes with a CD4+CD56+ surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with Hepatitis B virus.
    Barnaba V; Franco A; Paroli M; Benvenuto R; De Petrillo G; Burgio VL; Santilio I; Balsano C; Bonavita MS; Cappelli G
    J Immunol; 1994 Mar; 152(6):3074-87. PubMed ID: 7511637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human lymphocyte responses to hepatitis A virus-infected cells: interferon production and lysis of infected cells.
    Kurane I; Binn LN; Bancroft WH; Ennis FA
    J Immunol; 1985 Sep; 135(3):2140-4. PubMed ID: 3926897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cell function during interferon treatment of delta hepatitis.
    Actis GC; Maran E; Saracco G; Rosina F; Baldi M; Brunetto M
    Prog Clin Biol Res; 1987; 234():305-8. PubMed ID: 3628385
    [No Abstract]   [Full Text] [Related]  

  • 16. Assignment of human natural killer (NK)-like cells to the T cell lineage. Single allospecific T cell clones lyse specific or NK-sensitive target cells via distinct recognition structures.
    Moretta A; Pantaleo G; Mingari MC; Melioli G; Moretta L; Cerottini JC
    Eur J Immunol; 1984 Feb; 14(2):121-5. PubMed ID: 6230242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus-DNA transfected myeloma cell-specific cytotoxic T cells in chronic hepatitis B patients.
    Kamogawa Y; Yamauchi K; Obata H; Chisaka O; Matsubara K
    Virology; 1992 Nov; 191(1):321-6. PubMed ID: 1413509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunologic staging of chronic active hepatitis B patients in Hawaii.
    Ching N; Lumeng J; Pon E; Ching CY
    Hawaii Med J; 1994 Feb; 53(2):44-5, 49. PubMed ID: 7514583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, serologic, and immunologic effects of human leukocyte interferon in HBsAg-positive primary hepatocellular carcinoma.
    Nair PV; Tong MJ; Kempf R; Co R; Lee SD; Venturi CL
    Cancer; 1985 Sep; 56(5):1018-22. PubMed ID: 2990662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of recombinant interferon-alpha on lymphocyte subpopulations and HLA-DR expression on liver tissue of HBV-positive individuals.
    Yoo YK; Gavaler JB; Chen K; Whiteside TL; van Thiel DH
    Clin Exp Immunol; 1990 Nov; 82(2):338-43. PubMed ID: 2242614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.